Careplus Group BhdXKLS:0163 EBITDA Margin % is -2.79% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Careplus Group Bhd ranks worse than 80.29% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Careplus Group Bhd's EBITDA for the
three
months ended in Mar. 2026 was RM-0.58 Mil. Careplus Group Bhd's Revenue for the
three
months ended in Mar. 2026 was RM20.65 Mil. Therefore, Careplus Group Bhd's EBITDA margin for the quarter that ended in Mar. 2026 was -2.79%.
Careplus Group Bhd (XKLS:0163) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Careplus Group Bhd EBITDA Margin % Related Terms
Careplus Group Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Careplus Group Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0163 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careplus Group Bhd EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Careplus Group Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careplus Group Bhd (XKLS:0163) has a EBITDA Margin % of -2.79% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Careplus Group Bhd and its competitors. According to the industry distribution chart, Careplus Group Bhd ranks #656 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 80.3%.
Is Careplus Group Bhd's EBITDA Margin % too high?
Careplus Group Bhd's current EBITDA Margin % is -2.79%. Based on the distribution chart, Careplus Group Bhd ranks #656 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Careplus Group Bhd's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Careplus Group Bhd ranks #656 out of 817 companies for EBITDA Margin %. This places Careplus Group Bhd in the lower half of its industry. The industry median EBITDA Margin % is 7.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Careplus Group Bhd and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careplus Group Bhd's current EBITDA Margin % is -2.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careplus Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, Careplus Group Bhd (XKLS:0163) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.09, compared to a current price of RM0.08 — trading 16.7% below its estimated fair value. The current EBITDA Margin % is -2.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Careplus Group Bhd (XKLS:0163), the current EBITDA Margin % is -2.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0163 has been successfully added to your 